ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000802.1|Succinoglycan_1 # 1 # 129 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.589	BGC0000802.1|Succinoglycan_1 	1	129	-	Loose	750	29.6462	tet(53)	38.46	3004589	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGCAGAACAACAACATTCTCGTGGTCGGCGGCGCCGGCTATATCGGCTCGCATACCTGCCTTCAGCTTGCGGCAAAGGGTTACCAACCCGTCGTTTACGACAACCTCTCCAACGGCCACGAGGAATTC	MQNNNILVVGGAGYIGSHTCLQLAAKGYQPVVYDNLSNGHEEF	MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE	11.11	gnl|BL_ORD_ID|2724|hsp_num:0	3290			12	126	tetracycline; minocycline; oxytetracycline
BGC0000802.1|Succinoglycan_2 # 661 # 2475 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.639	BGC0000802.1|Succinoglycan_2 	661	2475	+	Loose	1000	251.136	msbA	37.61	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCATTTACTCGTTTCACGGCGCGCAACCGCGCCTTCCGTAGCGTTTTTCGATTCTCCTGGGACCATTGGAAGAAGCAGCCGGTGCGGCTCGCGGCTCTTCTTCTAACTGTGCTGCTTTCGACGCTCGCCGATGTGCTTACGCCGCTCTACTCCGGCCGGCTGGTCGACGCGGTGATTTCAGGTGCGGCGAGCGACGACGTCGCCTGGAATGCGGCGATGGCTGCCTTCATGATGCTGATGGCCCTGTCGTTCGGTGCCATCATCCTCAGGCATGTGACCTTCATGGGTATCGTCAGCCTCACGCTGAAGATGATGTCGGATATCGCCGCGGCCGCCTTTCATCACATCCAGCGGTTCTCCAGTGACTGGCACGCCAACAGCTTCGCCGGTTCGACGGTCCGCAAGGTGACGCGCGGCATGTGGGCACTCGATCTCTTGAACGATACGCTCCTCGTCGCGCTTTTCCCTTCTATCGTCATGCTGGTCGGCTCCACGGCGCTGATGGCCTGGTACTGGCCGATGATGGGGGTGATCATCGGGCTCGGCTCGATCGCCTTCATCGCCGTCACCGTTTCCCTGTCGCTCGGCTATGTGGCGCCGATGGCGAGCCTTGCCAACAGCTGGGACACGAGGCTTGGCGGGGCGCTCGCCGATGCGGTCAGCTGCAATACCGTCGTCAAGGCCTTCGGTGCGGAAGGGCGCGAGGACGCGCGTCTCGCCAAGGTTCTCCGCAAATGGGAGAACCGGACGCGGCGCACCTGGTCGCGCGGCACGCTCAACGGTACCGCGCAGGGCGCAATGCTGCTCGTCCTGCGCGCGGCCGTGATCGGCTTTGCCCTCCTGCTGTGGGCGAGAGGGCAGGCGACCGCAGGCGACATAACCTTCGTGCTCACCTCGTTCTTCATCCTGCAGGGCTATCTGCGGGAGGTGGGGATGCATATCCGCAACCTGCAGCGGTCGATCAACGACATGGAGGAGCTCGTCGCCATTCACGCCCAGCCGCTCGGCGTCGAGGACCGGCCAGGCGCAAAGCCCATCCGCATCACCGAGGGCGAGATCGAGTTCCGCGATGTGACGTTCCACTATGGAGCCCATCGCGCGCCTCTCTACGAGGGCTTCTCGGTCAACATCGCGGCCGGCGAGCGTGTCGGTCTCGTCGGGCACTCCGGTTCGGGCAAGACGACGTTCATCAAGCTGATACAGCGTCTCCATGATTTGAATGCCGGTGAGATCCGCATTGACGGGCAGAATATCGCCGACTTCACCCAGGCGTCGCTGCGCCAGCAGATCGCCATCGTGCAGCAGGAGCCGATACTGTTTCACCGCTCGCTTGCCGAGAATATCGCCTATGCACGGCCGGGGGCGACGCAACGCGACATCGAGGAGGCGGCAAGGCTTGCGAGCGCGCATGACTTCATCGCCGCATTGCCGAAGGGCTATGGGACGCTGGTCGGCGAACGTGGCGTGAAGCTCTCGGGCGGCGAGCGCCAGCGGGTGGCGATTGCCCGCGCCTTTCTGGCGGATGCACCCATCCTCATCCTGGACGAGGCGACGTCGAGCCTCGATTCGGAGTCCGAGGTGCTGATCCAGCAGGCGATGGAGCGGCTGATGACGGGGCGCACCACGCTCGTGGTCGCACACCGGCTTTCCACCGTACGTGCGCTGGACCGCCTTCTGGTCTTCGATCGCGGCCGCATTGCGGAAGAAGGCGACCACGGCGCGCTCATCCGCGTCAAGGGCGGCATCTATCGCAGTCTCTTCGAAAGACAGGCGCTGGAACTGACGAAGGGTCTCATCCTCAGCGAGGGATGA	MAFTRFTARNRAFRSVFRFSWDHWKKQPVRLAALLLTVLLSTLADVLTPLYSGRLVDAVISGAASDDVAWNAAMAAFMMLMALSFGAIILRHVTFMGIVSLTLKMMSDIAAAAFHHIQRFSSDWHANSFAGSTVRKVTRGMWALDLLNDTLLVALFPSIVMLVGSTALMAWYWPMMGVIIGLGSIAFIAVTVSLSLGYVAPMASLANSWDTRLGGALADAVSCNTVVKAFGAEGREDARLAKVLRKWENRTRRTWSRGTLNGTAQGAMLLVLRAAVIGFALLLWARGQATAGDITFVLTSFFILQGYLREVGMHIRNLQRSINDMEELVAIHAQPLGVEDRPGAKPIRITEGEIEFRDVTFHYGAHRAPLYEGFSVNIAAGERVGLVGHSGSGKTTFIKLIQRLHDLNAGEIRIDGQNIADFTQASLRQQIAIVQQEPILFHRSLAENIAYARPGATQRDIEEAARLASAHDFIAALPKGYGTLVGERGVKLSGGERQRVAIARAFLADAPILILDEATSSLDSESEVLIQQAMERLMTGRTTLVVAHRLSTVRALDRLLVFDRGRIAEEGDHGALIRVKGGIYRSLFERQALELTKGLILSEG	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	103.78	gnl|BL_ORD_ID|2185|hsp_num:0	2423			456	1737	metronidazole
BGC0000802.1|Succinoglycan_4 # 3329 # 3685 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.602	BGC0000802.1|Succinoglycan_4 	3329	3685	+	Loose	450	23.0978	rmtD	37.93	3002667	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGTTCCGCATCACCAAGGAATTCCATTTCTCCGCCTCGCACCAGCTGAAGAGCCTGCCGGCCGAGCATCAATGCGCGCGGCTGCATGGGCACAATTACATCGTCGAGGTCGAGCTTTCCGGCGAAACGCTGAACGAGCATGGATTCGTGCGCGACTACCACGAACTCGCGCCACTGAAGCAATATATCGACGAGTGCTTCGACCACCGCCATCTGAACGACGTGCTCGGGCACGATCGGGTGACGGCGGAATGCCTGGCGCAGCATTTCTACGAATGGTGCCAGGCTCGGCTGCCCGAGACGACAGCCGTTCGCGTCAGCGAGACAGCGAAGACCTGGGCGGAATATCGGCCATGA	MFRITKEFHFSASHQLKSLPAEHQCARLHGHNYIVEVELSGETLNEHGFVRDYHELAPLKQYIDECFDHRHLNDVLGHDRVTAECLAQHFYEWCQARLPETTAVRVSETAKTWAEYRP	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDVDKAAREALHGVTGAFMTEREYKRAMEMAAARDWEALLGMHASTRERLPVESMDRVFDQLFEASGTPARILDLACGLNPVYLAHRLPNAAITGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEANAALLFKVLPLLERQRAGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	47.77	gnl|BL_ORD_ID|1702|hsp_num:0	1843			612	690	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000802.1|Succinoglycan_5 # 3682 # 4419 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.615	BGC0000802.1|Succinoglycan_5 	3682	4419	+	Loose	500	26.5646	FIM-1	34.04	3004786	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	FIM beta-lactamase	ATGATCCACACCCGATCGAACGAAATCCGCGTCAGCGAGATATTCGGACCGACGATCCAGGGGGAGGGGGTGCTGATCGGCCTGCCAACGGTATTCGTCAGGAGCGGCGGCTGCGATTACCGCTGTTCCTGGTGCGACAGCCTCCATGCCGTCGACAGCAACTACCGGCATGAATGGCAAACGATGTCGACCGAGGAGGTTTGGCAGGAAATCGTTCGGCTTTCGGGCGGTGAAGCTGTGATGGTTTCGCTATCGGGCGGCAACCCGGCAATACAGCCGCTCGGCGATCTGATCGGCCGCGGGCACGAAAATGGCTATCGATTCGCCCTGGAAACGCAAGGTTCGGTCGCTCGCGACTGGTTCGCCAATCTCGACGTGCTGGTGCTCAGTCCTAAGCCGCCCTCGAGCGGGATGGAGACCGACTGGGAAGCCTTGGACGACTGTCTCCGCAGTGCTGGAAACAAGCCGCAGACGGTATTGAAATTCGTGGTCTTCGATGAAGCGGACTATGCCTATGCAATGACAGCTGCCGCGCGCCATCCGCATCTTCCCGTCTATCTGCAGCCCGGCAACCATACTCCGCCGCCCGCGGAGGAGGCGGACGCGCCGATCGATATCGACGGCGTGATGGAGCGGATGCGCTGGTTGGTCGATAGGGTTGTTGCCGACAGGTGGTTCGAGGCGCGGGTCCTGCCGCAACTGCATGTCCTCATCTGGGGCAACAGGCGCGGCGTTTGA	MIHTRSNEIRVSEIFGPTIQGEGVLIGLPTVFVRSGGCDYRCSWCDSLHAVDSNYRHEWQTMSTEEVWQEIVRLSGGEAVMVSLSGGNPAIQPLGDLIGRGHENGYRFALETQGSVARDWFANLDVLVLSPKPPSSGMETDWEALDDCLRSAGNKPQTVLKFVVFDEADYAYAMTAAARHPHLPVYLQPGNHTPPPAEEADAPIDIDGVMERMRWLVDRVVADRWFEARVLPQLHVLIWGNRRGV	MRPLPHSYLKSLVICLLTAFAALTPVVNSGVQAAQPKDVPVTFTAITQGVWMHTSMKHMENWGHVPSNGLIVEKGDFSILVDTAWDDPQTAQIIEWSKDTLKKPIRWAVFTHAHDDKMGGVAALRQQGIVTYAAADSNRMAPQNGLTPAEHDLIFDSEHSTSVLHPLVIFDPGPGHTRDNIVVGLPEQGIVFGGCLIRPSGSTSLGNTADADLAHWKTAVLAVAQRFAEAQQIIPSHGPMAGRELFELTAQLAEKASIPSTP	93.51	gnl|BL_ORD_ID|2173|hsp_num:0	3584			516	654	
BGC0000802.1|Succinoglycan_6 # 4466 # 6286 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.635	BGC0000802.1|Succinoglycan_6 	4466	6286	-	Loose	1100	56.6102	tetB(60)	23.14	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAGAACCAAACCGGCAATGAGACTCGGGCCCGAACGCCCGCCACCCCATCGGAAGGCAGCAGTATCTGGCAGCAGTTCGAGATGATGCGGCACGCTTTCGTCGCCTCGCCGGTTTTGAAGCCTATCCTATGGCTGGCGGCCGGCAGCTTCACCATAATCATCGTCACCGCCATCGGGCAGATCGTTCTCAACCGCTGGTACCGGCCCTTCTTCGACGCGATCGAACGTCGCGATCTCAACAGTTTCTTCTATCAGCTTATGCTGTTCGTCCTCCTCGCCGGCGTCCTGCTGGTGTTCAACGTCGCTCAGCAGTGGCTCAATCAGATGGTGCGCCTGAAGCTGCGCGAAGGGTTGACATTGGACTTGATCGGCGAATGGATGCGGCCGCGGCGTGCCTTCCGGCTGGCCAATGCCGGCACGATCGGCGTGAACCCGGATCAGCGCATGCAGGAAGATGCCGGCCACCTTGCCGATCTCACGACCAGCCTCGGATTCGGGCTTTTGCAATCGTCGATCCTGCTCATTTCGTTCGTTGGCGTCCTCTGGTCCCTTTCAGCGGGCTTTGCCTTCCAGATCGGCGAACGGTCGCTGGAAATTCCCGGCTACATGGTGTGGGCTGCAATCCTCTACGCCGGCTCCGCGTCGTGGCTGAGTTGGCTCGTCGGCCGCCGGCTGATCGTTCTGAACGGCGAGCGCTACGCCCGCGAAGCCGATCTTCGCTTCTCGATGATGCACGCCAACGAGCATATCGACGGCATCTCGCTTGCGGGCGGCGAGGCTGGGGAGCGACGGCGCCTGCAACTCGACCTCTCCTCCGTGCTCGACGCCACGCGCAAGATATTCCGAGCCGAGATCAATCTTGCCTGGGTTCAGGACGGCTACGGCTGGGTCACGGTCGTCGCACCTATTCTCGTTGCAGCGCCAGTTTATTTCGCGGGAAACATTAGCTTCGGCGGCCTTATGATGGCGGTGGGGGCGTTCAACCAGGTGCACTCGTCGTTGAAATGGTTCGTCGCCAATGTCAGCGCCATCACGGATTGGCGCGCAACGCTGCTGCGCGTTGCCGCCTTTCGCCGGGCGCTGATCACGGCAGACACGCTGCACGGCGATGAAAAGCGTATCGAATTCGTCGAGAACGAGAGTGCCACCATGACGTTCGAGAACCTTGAGGTGGTCTCCCGCTCGGGTCGAACCAGGCTGGCGGAGTCTCGTATCGAGATCTCCCCCGGCCAGCGGGTCAACATCATCGGCGATCCGCGTGCCGGGAAGACGCTGGTCTTCCGGGCGCTCGCCGGGCTCTGGCCCTGGGGAAACGGCCGCGTGGGAATGCCGGCCGGCGAAGCCGTGGCCTTCATTCCTCGCGCGCCTTATTTCCCCCGCGGCCGCCTGCGCGACGCCCTTGCCTATCCGCACGCCGACAGTTTCCCCGACAAGGTGCTCGTGACTGCGCTTTCGAAGGTCGGGCTCGACCATCTCGCGACGTCGCTCGATCGCGAGGCCCGTTGGGAACGCGAACTCGGTGACGACGAGCAGCGCCTCCTGGCCTTTGCCCGGCTCCTCGTGCAGAAACCCCGTTGGGTGGTCATCGACGAAGCGCTGGAGACCATGGACGCCGATGCCCTGAAACGGGCCCTTTCGATCTTCGAGGCCGACCTGCGGGAGACCGCGGTGATCAAGATCGGCCGAACGCCGCGAAACGGAGTGCAGTTCTCCCGCGTGATCCATCTCGTCAAGGACGCCGAAGCTCCGGCCCTGAAGCCGGTTCGCCTCGGCGGAGGTGTTTCGGGCCTGGAGGTGGCCGCACGCGGTGCGCCTTGA	MKNQTGNETRARTPATPSEGSSIWQQFEMMRHAFVASPVLKPILWLAAGSFTIIIVTAIGQIVLNRWYRPFFDAIERRDLNSFFYQLMLFVLLAGVLLVFNVAQQWLNQMVRLKLREGLTLDLIGEWMRPRRAFRLANAGTIGVNPDQRMQEDAGHLADLTTSLGFGLLQSSILLISFVGVLWSLSAGFAFQIGERSLEIPGYMVWAAILYAGSASWLSWLVGRRLIVLNGERYAREADLRFSMMHANEHIDGISLAGGEAGERRRLQLDLSSVLDATRKIFRAEINLAWVQDGYGWVTVVAPILVAAPVYFAGNISFGGLMMAVGAFNQVHSSLKWFVANVSAITDWRATLLRVAAFRRALITADTLHGDEKRIEFVENESATMTFENLEVVSRSGRTRLAESRIEISPGQRVNIIGDPRAGKTLVFRALAGLWPWGNGRVGMPAGEAVAFIPRAPYFPRGRLRDALAYPHADSFPDKVLVTALSKVGLDHLATSLDREARWERELGDDEQRLLAFARLLVQKPRWVVIDEALETMDADALKRALSIFEADLRETAVIKIGRTPRNGVQFSRVIHLVKDAEAPALKPVRLGGGVSGLEVAARGAP	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	104.66	gnl|BL_ORD_ID|2307|hsp_num:0	2646			837	1539	tetracycline
BGC0000802.1|Succinoglycan_7 # 6325 # 6882 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.588	BGC0000802.1|Succinoglycan_7 	6325	6882	-	Loose	1900	26.9498	acrD	27.59	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCGGTTTCGGCACCGTGGGGTTGCGATGTCTCGATTCGGCGATCAGGCCGAGAATCGTGCCCGGCAACTGCGAGCGAGGCGCGGATGAGGGCGGCGATAACGGTTGGGGCCGGCAGATCACAAAAGTTTACTGGAAAGCCCGCCGGGCCGGTCAGGCGCTTCCCACGCGACATATGGAAAAGAAATCTCGAATACATTCAAAGGGTCGCAGGTCGCTGCTGCATACTCGCCGATGCCGTTCCGCAAGGCCGGTGGGGTCTGACTTCCTTGGAACGGACCAAAATCCGGTTTTCAGGCGGCGCCGTTATCCATACATTGAACGGTATGGGGATTTCTAATTTAGCTGCATCACAGTTTTTTAACGGCATATTTGCTTCGTACCGACTGCTGCTCGGCACTGAATCTCCACTTGGCGGATCGCCGCCGCCGAGCATGAAACCGGGCGCTGCCATACGGCACTCGCCCCGGCCGGCAGATTGTTCAAGCCACAGAGGCGACCGCAAACACAACGTCCCGGATCTTTCCAATGGCCGCGGGTACCGACCGTCGGATTAG	MSVSAPWGCDVSIRRSGRESCPATASEARMRAAITVGAGRSQKFTGKPAGPVRRFPRDIWKRNLEYIQRVAGRCCILADAVPQGRWGLTSLERTKIRFSGGAVIHTLNGMGISNLAASQFFNGIFASYRLLLGTESPLGGSPPPSMKPGAAIRHSPRPADCSSHRGDRKHNVPDLSNGRGYRPSD	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	17.84	gnl|BL_ORD_ID|1309|hsp_num:0	1427			2289	2622	
BGC0000802.1|Succinoglycan_8 # 7134 # 7385 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.603	BGC0000802.1|Succinoglycan_8 	7134	7385	+	Loose	1800	23.483	MexD	50.0	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCTATTTCACCCTCCAACATTGGCGACAAGGAAGCCGCTCCGATGCCCAACGGCGACATCGCCGCTCGCGTCAAGGCCGCGCGTGAAGCGGTCGGCTACAGCATCGAGGATCTCGCGGTCACCTGCGGCCTCGCCGTCGTCGAAATCAACGATATCGAGAATGGCACTGACTTCAGTCCAGCGAAGCTCAAGCGCGTCGCCGGCGCACTACAGGTGCCGCTTTCCCATTTCCTGCCCACAGAAATGTGA	MSISPSNIGDKEAAPMPNGDIAARVKAAREAVGYSIEDLAVTCGLAVVEINDIENGTDFSPAKLKRVAGALQVPLSHFLPTEM	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	7.96	gnl|BL_ORD_ID|1485|hsp_num:0	1523			786	852	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000802.1|Succinoglycan_9 # 7324 # 7860 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.611	BGC0000802.1|Succinoglycan_9 	7324	7860	-	Loose	480	35.8094	adeR	28.44	3000553	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACCACGGAGACCAATATCGGGTGCTCGTCGTGGAGGACGAGTTTCTTGTCGCACTGCAGATTGAAGCTGATCTCGTCGCTGCCGGCTACTCGGTGATCGGCCCATTCACGAGCCTCGCTCAGTCGATCTCCGCCGCCCGCGCGCATCCGTTCGATATCGCTACTCTCGATCTCAATCTGCGCGGCGAGTTCGCCTATCCGCTCGTCGACGAACTCATGGAGCGCGAGGTGCCGGTGCTTCTGTTGACCGGTTATACGGCGCTTGACTTGCCTGAACGATTTCGTGCCCTGCCCCGCCTGGCAAAACCCTTCGACGGCACGCAACTCAGAAGATCGAAGGCCTCCACCCGTTTAATGGCAGCCCGGCCGGCGCGTGAGCCGGCCGGTGCTAGATTACAAATGGGTCACGGTGCTGAGCGGTTGCGGCACAAGGTGGCGGAACGGCGCACCCTTTTTTCTACTGCCGCCGATCTCACATTTCTGTGGGCAGGAAATGGGAAAGCGGCACCTGTAGTGCGCCGGCGACGCGCTTGA	MNHGDQYRVLVVEDEFLVALQIEADLVAAGYSVIGPFTSLAQSISAARAHPFDIATLDLNLRGEFAYPLVDELMEREVPVLLLTGYTALDLPERFRALPRLAKPFDGTQLRRSKASTRLMAARPAREPAGARLQMGHGAERLRHKVAERRTLFSTAADLTFLWAGNGKAAPVVRRRRA	MFDHSFSFDCQDKVILVVEDDYDIGDIIENYLKREGMSVIRAMNGKQAIELHASQPIDLILLDIKLPELNGWEVLNKIRQKAQTPVIMLTALDQDIDKVMALRIGADDFVVKPFNPNEVVARVQAVLRRTQFANKATNKNKLYKNIEIDTDTHSVYIHSENKKILLNLTLTEYKIISFMIDQPHKVFTRGELMNHCMNDSDALERTVDSHVSKLRKKLEEQGIFQMLINVRGVGYRLDNPLAVKDDA	72.06	gnl|BL_ORD_ID|412|hsp_num:0	456			42	357	tigecycline; tetracycline
BGC0000802.1|Succinoglycan_10 # 7857 # 10580 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.634	BGC0000802.1|Succinoglycan_10 	7857	10580	-	Loose	700	31.5722	Escherichia coli mdfA	33.33	3001328	protein homolog model	n/a	n/a	tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCACGGCGCAGAAATTCTACCCAAAACAACGATTGACGATGTCACGACTTCTGACACGCCCGATTACCGCGCCGTGCTCGACGCCCTTGCGGTGCCCGTTTATGCGACCGACGCCGAGGGCATCGTCACCTACTGCAACGCCGCGGCTGCAGCCGTTGCTGGTCGTGAGCCGGAGCTCGGCAAGGATCGCTGGTGCGTCAGTTGGCAACTGAGGCGGCCGGATGGCTCACCCCTCCCGCACGACGAGTGCCCAATGGCGCGCACATTGAAAGAAGGACAGCCGGTCAGGGGCGAAGAAGTGGTGGCGGTCCGGCCGGACGGCGCCTCGGTCCCGCTTCTGCCGCATCCGACGCCGATCTTCGACGACACGGGCGCATTGACCGGAGCCGTCAATGTCCTCATGGACCTCAGTGGCGCGAAGGATATGGAGCGCAGTTCCCGCTATCTCGCCGCGATCGTCGAATCTTCCGACGATGCCATCGTCGCGAAGAACCTGGACGGGATCATCACCAGCTGGAACCGCGGCGCGCAGCGGCTTTTTGGCTATGCGGCCGAAGAAGTTATCGGCGAGTCGATCACCATTCTCATACCGCCAGAACGCCTGAGCGAGGAGCCCGGCATCCTCGAACGCATTCGCAGAGGCGAACTGGTCGACCACTTCGAGACCAAGCGCCGGCGCAAGGACGGGACCCTGGTGGACATTTCGCTTACCGTTTCCCCAGTCAGGGATGCCACCGGCCGCATCATCGGCGCTTCCAAGATCGCCCGCGACATCACCGAGACGAAAAGCGCAGCAGAGGCACTGGCTGCCCGCTTTCGTGAGCAGGCCGCGTTGTATCGTCTGACCGAAAGGGTGCAGCGTACCAAACGGATAGAAGAGGTCTACGAGGCGACACTGGATGCCATTCAGGGCGCGTTGAATTGCGACCGCGCCTCAATTTTGCTCTTCGATGAGGCAGGGACCATGCGGTTCGTCGCCGCGCGCGGCCTTTCGGAGCATTATCAGCGCGCTGTCGACGGACACTCCCCTTGGATTACGGGAGCGAACGAACCCGAGCCGATCTTCGTCGAGAATGTCGACGACGCGGAATTCTCGCGAGAGCTGAAGGAGAGCATAGTCGGCGAAGGCATCGCCGCGCTCGGCTTCTTCCCGCTCGTCACGGAAGGCAGGCTGATCGGGAAATTCATGACCTACTACGACCGGCCACACCGGTTTGCGGATTCCGAGATCGGCATGGCGCTCACCATCGCGCGACAACTCGGATTCAGCATCCAGCGCATGAGAGCCGAATATGCACGGCGCCAGGCCGAGGAGCAGCTGCGCCGCAACGAGGCGAACGAAAGGGCGCACGCGGCCGAGTTGGCGGCGATCATGGAGGCCGTGCCGGCGTTGATCTGGATTGCACGCACGCCCGATTGCCGCGTCATCAGCGGCAATAACAGCTCCTACGAGATTCTGCGGCTGCCGCACGACAGCAATCTGTCGATGTCGGCGCCTCCCGGCGAGCACCCCACCAACTTCCGCGTTTTCTCTGAAGGGCGCGCATTGTCGCCGGAGGAGCTGCCCGTACAAAGGGCGGCTCGCGGCGAAGAGGTTCAGAATTTCGAGGAGGAGGTGCGCTTCGACGACGGAAGCTCCCGTCATATCTTCGGCAACGCGACTCCGCTGCGCGACGTCACAGGCGAAGTGGTCGGAGCTGTCGCTGCCGCTGTCGACATCACCGGGCGCAAGCAGGCGGAGGAGGCGCTCCCAGGAAAGCGAACGGCCCTGCAGCTCGCACTGGATGCCGGGCATATGGGCGCCTGGGAGTGGAACCTCGAAACGGGTGAGGTGATCTGGTCGCCGGGGTTGGAGGCGCTTCACCGTATTGAGCCCGGATCGTTCGGAGGAACGCTGGCCGACTTCAAGCGCGACATACACCCGGACGATCTTCCCTTGATCGAGCGCGAGATGGCCAGGGCGATCGAGACAGACGGAGACTACCACGTCGTCTACCGTGCTCAGCTTCCCGACGGGACAATCCGGTGGATGGAGGCTTTCGGACAGCTTTCGCCGCGCAACGGCCCCAAAAGGCGTTTGACCGGCGTCTGCATGGACATCACGGAGCGCAGGGAGGCCGAAGCGCAGCGCAATCTCCTCGTCGCCGAGCTCAGCCACCGCGTGAAGAACACGCTGGCGATCGTCGGGTCGATCGCACGGCAAACATTCTCGACCAATCCGGACGCCAAAGCGGCACACCGTTCCTTCGATGCACGCATAAGGGCCCTCGCGCAAACCCATACGCGCCTGGCGGAGGCGAGCTGGTCGGGCGTCTCCCTGAAAACCGTGCTGTTCGACGAATTGTCGCCGTATCACGACGACAGCAGGACGAATGTGACCCTTGCGGGCCCGCCGGCGATGCTGCCGCCCAAGCATGCGCTGACACTCGGCATGGCGGCGCACGAGCTTGCAACCAATGCCGCGAAACATGGGGCACTCTCCGTCAGGAGCGGAAAAGTCGATATCGAGTGGATGATCGACGTGGCAAGTGAGCGGCTGCGGATCTGCTGGAGCGAGACGGGCGGACCGGCCGTTGTCGCGCCGAAGCATAATGGCTTCGGCCGTCTGCTGCTCGAGCGGGTTCTCGCCTCGGATCTTGGCGGTGAAGTGCATCTCGAGTTCGCGCCGCAAGGGCTGGTATGCACGATCGATGTTCCCTATCCGCGCGGAGCCCCCGGATGA	MHGAEILPKTTIDDVTTSDTPDYRAVLDALAVPVYATDAEGIVTYCNAAAAAVAGREPELGKDRWCVSWQLRRPDGSPLPHDECPMARTLKEGQPVRGEEVVAVRPDGASVPLLPHPTPIFDDTGALTGAVNVLMDLSGAKDMERSSRYLAAIVESSDDAIVAKNLDGIITSWNRGAQRLFGYAAEEVIGESITILIPPERLSEEPGILERIRRGELVDHFETKRRRKDGTLVDISLTVSPVRDATGRIIGASKIARDITETKSAAEALAARFREQAALYRLTERVQRTKRIEEVYEATLDAIQGALNCDRASILLFDEAGTMRFVAARGLSEHYQRAVDGHSPWITGANEPEPIFVENVDDAEFSRELKESIVGEGIAALGFFPLVTEGRLIGKFMTYYDRPHRFADSEIGMALTIARQLGFSIQRMRAEYARRQAEEQLRRNEANERAHAAELAAIMEAVPALIWIARTPDCRVISGNNSSYEILRLPHDSNLSMSAPPGEHPTNFRVFSEGRALSPEELPVQRAARGEEVQNFEEEVRFDDGSSRHIFGNATPLRDVTGEVVGAVAAAVDITGRKQAEEALPGKRTALQLALDAGHMGAWEWNLETGEVIWSPGLEALHRIEPGSFGGTLADFKRDIHPDDLPLIEREMARAIETDGDYHVVYRAQLPDGTIRWMEAFGQLSPRNGPKRRLTGVCMDITERREAEAQRNLLVAELSHRVKNTLAIVGSIARQTFSTNPDAKAAHRSFDARIRALAQTHTRLAEASWSGVSLKTVLFDELSPYHDDSRTNVTLAGPPAMLPPKHALTLGMAAHELATNAAKHGALSVRSGKVDIEWMIDVASERLRICWSETGGPAVVAPKHNGFGRLLLERVLASDLGGEVHLEFAPQGLVCTIDVPYPRGAPG	MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG	221.22	gnl|BL_ORD_ID|2419|hsp_num:0	37			555	789	tetracycline; benzalkonium chloride
